{"id":21283,"date":"2021-12-15T10:02:50","date_gmt":"2021-12-15T08:02:50","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=21283"},"modified":"2021-12-15T10:02:50","modified_gmt":"2021-12-15T08:02:50","slug":"lietuva-pasieke-pirmoji-5-11-metu-vaikams-skirtu-covid-19-vakcinu-siunta","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2021\/12\/15\/lietuva-pasieke-pirmoji-5-11-metu-vaikams-skirtu-covid-19-vakcinu-siunta\/","title":{"rendered":"Lietuv\u0105 pasiek\u0117 pirmoji 5\u201311 met\u0173 vaikams skirt\u0173 COVID-19 vakcin\u0173 siunta"},"content":{"rendered":"

Gamintojas \u201eBioNTech ir Pfizer\u201c pirmadien\u012f pristat\u0117 \u012f Lietuv\u0105 pirm\u0105sias vakcinas, skirtas 5\u201311 met\u0173 vaik\u0173 skiepijimui nuo COVID-19 ligos. Pirm\u0105j\u0105 siunt\u0105 sudaro 78 t\u016bkst. suma\u017einto t\u016brio \u201eComirnaty\u201c vakcinos dozi\u0173, kurios per kelias dienas bus paskirstytos skiepijan\u010dioms asmens sveikatos prie\u017ei\u016bros \u012fstaigoms. Vakcinuotis nuo koronaviruso infekcijos jau u\u017eregistruota daugiau nei 2 t\u016bkst. \u0161ios am\u017eiaus grup\u0117s vaik\u0173.<\/strong><\/p>\n

5\u201311 met\u0173 vaik\u0173 vakcinacija nuo COVID-19 ligos prasid\u0117s gruod\u017eio 15\u201316 dienomis, o registruoti savo vaikus gyventojai gali jau dabar internetu www.koronastop.lt<\/a> arba trumpuoju numeriu 1808. Vienas i\u0161 t\u0117v\u0173 (\u012ft\u0117vi\u0173), glob\u0117j\u0173 arba r\u016bpintoj\u0173 tur\u0117s kartu su vaiku atvykti \u012f vakcinacijos viet\u0105 ir atvykus pateikti savo ir vaiko asmens tapatyb\u0119 patvirtinan\u010dius dokumentus. Atvykimas yra traktuojamas kaip sutikimas skiepytis, tod\u0117l sutikimo pa\u017eymos pildyti nereik\u0117s.<\/p>\n

5\u201311 met\u0173 am\u017eiaus vaikai bus skiepijami specialiai \u0161iai am\u017eiaus grupei skirta ma\u017eesnio t\u016brio \u201eComirnaty\u201c vakcina (gamintojas \u201eBioNTech ir Pfizer\u201c). Vakcina jaunesniems vaikams turi 10 mikrogram\u0173 COVID-19 mRNR (veikliosios med\u017eiagos), vaikui bus suleid\u017eiama 0,2 ml t\u016brio vakcinos doz\u0117. 12 met\u0173 ir vyresniems gyventojams skirtose \u201eComirnaty\u201c vakcinose yra 30 mikrogram\u0173 COVID-19 mRNR, o vienos doz\u0117s t\u016bris sudaro 0,3 ml.<\/p>\n

\u012evertinusi klinikini\u0173 tyrim\u0173 duomenis, Europos vaist\u0173 agent\u016bra rekomendavo<\/a> skiepyti 5\u201311 met\u0173 vaikus \u201eComirnaty\u201c vakcina, nes ji veiksmingai apsaugo \u0161ios am\u017eiaus grup\u0117s asmenis nuo COVID-19 ligos.<\/p>\n

Tiek suaugusieji, tiek vaikai yra skiepijami \u012f \u017easto raumen\u012f, tarp pirmos ir antros \u201eComirnaty\u201c vakcinos dozi\u0173 daroma bent 21 dienos pertrauka.<\/p>\n

\"\"<\/p>\n

SAM Spaudos tarnyba<\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Gamintojas \u201eBioNTech ir Pfizer\u201c pirmadien\u012f pristat\u0117 \u012f Lietuv\u0105 pirm\u0105sias vakcinas, skirtas 5\u201311 met\u0173 vaik\u0173 skiepijimui nuo COVID-19 ligos. Pirm\u0105j\u0105 siunt\u0105 sudaro 78 t\u016bkst. suma\u017einto t\u016brio \u201eComirnaty\u201c vakcinos dozi\u0173, kurios per kelias dienas bus paskirstytos skiepijan\u010dioms asmens sveikatos prie\u017ei\u016bros \u012fstaigoms. Vakcinuotis nuo koronaviruso infekcijos jau u\u017eregistruota daugiau nei 2 t\u016bkst. \u0161ios am\u017eiaus grup\u0117s vaik\u0173. 5\u201311 met\u0173…<\/p>\n","protected":false},"author":3,"featured_media":21284,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-21283","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-5xh","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2021\/12\/19663_5c6c78efbb9bec681c1f8a99843836e2.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/21283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=21283"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/21283\/revisions"}],"predecessor-version":[{"id":21285,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/21283\/revisions\/21285"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media\/21284"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=21283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=21283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=21283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}